PMID: 9176074Apr 1, 1997Paper

In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease

Gut
J M ReimundB Duclos

Abstract

Inflammatory cytokines, including tumour necrosis factor-alpha (TNF-alpha) and interleukin (IL)-1 beta, have been implicated as primary mediators of intestinal inflammation in inflammatory bowel disease. To investigate the in vitro effects of oxpentifylline (pentoxifylline; PTX; a phosphodiesterase inhibitor) on inflammatory cytokine production (1) by peripheral mononuclear cells (PBMCs) and (2) by inflamed intestinal mucosa cultures from patients with Crohn's disease and patients with ulcerative colitis. PBMCs and mucosal biopsy specimens were cultured for 24 hours in the absence or presence of PTX (up to 100 micrograms/ml), and the secretion of TNF-alpha, IL-1 beta, IL-6, and IL-8 determined by enzyme linked immunosorbent assays (ELISAs). PTX inhibited the release of TNF-alpha by PBMCs from patients with inflammatory bowel disease and the secretion of TNF-alpha and IL-1 beta by organ cultures of inflamed mucosa from the same patients. Secretion of TNF-alpha by PBMCs was inhibited by about 50% at a PTX concentration of 25 micrograms/ml (IC50). PTX was equally potent in cultures from controls, patients with Crohn's disease, and those with ulcerative colitis. The concentrations of IL-6 and IL-8 were not significantly modified in...Continue Reading

Citations

Oct 19, 2001·Biochemical and Biophysical Research Communications·J M ReimundC D Muller
Jan 25, 2002·The Bulletin of Tokyo Dental College·T HisamatsuJ Nishida
Mar 7, 2006·Nature Reviews. Drug Discovery·Joshua R Korzenik, Daniel K Podolsky
Oct 13, 2006·Current Opinion in Gastroenterology·R B Heuschkel
Nov 5, 1999·Critical Care Medicine·A M ChavezM P Fink
Jun 22, 2001·Immunopharmacology and Immunotoxicology·M AltamuraS Miniello
Dec 1, 2001·Expert Opinion on Biological Therapy·M H HoltmannM F Neurath
Jan 5, 2002·Expert Opinion on Investigational Drugs·S V Kane
Dec 8, 2009·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Simone KrebsBilal Omer
Sep 13, 2003·British Journal of Clinical Pharmacology·E Carty, D S Rampton
Jun 15, 2007·Journal of Clinical Pharmacology·Bruce E Sands, Gilaad G Kaplan
Aug 9, 2008·The Journal of Obstetrics and Gynaecology Research·Afsaneh MohammadzadehFarzaneh Mohammadzadeh
Dec 28, 2006·Journal of the American Academy of Dermatology·Julia E GravesMichael P Heffernan
Nov 29, 2005·La Revue de médecine interne·M KoenigH Rousset
Jun 5, 2004·Gastroenterology Clinics of North America·Joshua R Korzenik
May 11, 2011·European Journal of Pharmacology·Theresa C PetersonJennifer M Raoul
Feb 18, 2017·International Journal of Molecular Sciences·Kazufumi FukutaMasahito Shimizu
Apr 16, 1998·European Journal of Clinical Investigation·J M ReimundP Poindron
Sep 28, 2000·The American Journal of Gastroenterology·A E BharuchaK D Lindor
Oct 8, 2004·Expert Opinion on Therapeutic Targets·Warren B Nothnick
Oct 24, 2006·Annals of the New York Academy of Sciences·Andreas LügeringTorsten Kucharzik
Oct 6, 2009·Molecular and Cellular Biochemistry·Jyotirmoy NandiRobert A Levine
May 20, 2009·Scandinavian Journal of Clinical and Laboratory Investigation·Sule PoturogluZeynel Mungan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.